MedicineBiology

Lidong Zhang, B. Fang

2005.3.1CANCER GENE THERAPY

DOI: 10.1038/sj.cgt.7700792

tlooto Summary

The tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is regarded as a potential anticancer agent but considerable numbers of cancer cells are resistant to apoptosis induction by TRAIL, and some cancer cells that were originally sensitive to TRAIL-induced apoptosis can become resistant after repeated exposure (acquired resistance).

Abstract

Abstract is not available.

Citation format

ZHANG, Lidong; FANG, B. Mechanisms of resistance to TRAIL-induced apoptosis in cancer. CANCER GENE THERAPY, 2005, 12: 228–237.